Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sanofi
  6. News
  7. Summary
    SAN   FR0000120578

SANOFI

(SAN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

SANOFI : Receives a Buy rating from Goldman Sachs

06/10/2021 | 08:29am EDT

Keyur Parekh from Goldman Sachs retains his positive opinion on the stock with a Buy rating. The target price is still set at EUR 105.


ę MarketScreener with dpa-AFX Analyser 2021
All news about SANOFI
05:50aBioNTech Doses First Patient in Mid-Stage Study of mRNA Cancer Vaccine
MT
05:00aPRESS RELEASEá : BioNTech Announces First Patient Dosed in Phase 2 Clinical Tria..
DJ
06/16PRESS RELEASE DATED JUNE 11, 2021 : New pivotal data at EHA 2021 reinforces suti..
PU
06/16ER+/ HER2-VE BREAST CANCER PIPELINE : Emerging Therapies and Key pharma players ..
AQ
06/16SANOFIá : Commits $52 Million, Other Guarantees For British Pension Scheme
MT
06/15SANOFIá : Berenberg reaffirms its Neutral rating
MD
06/15Belgian agri-tech firm Biotalys plans listing in Brussels
RE
06/14SANOFIá : - New pivotal data at EHA 2021 reinforces sutimlimab as a first-in-cla..
AQ
06/14SANOFIá : provides update on Aubagio (teriflunomide) submission for children and..
AQ
06/11SANOFIá : Drug Blocks Red Blood Cell Destruction In Late-Stage Study
MT
More news
Financials
Sales 2021 37 033 M 44 114 M 44 114 M
Net income 2021 5 909 M 7 039 M 7 039 M
Net Debt 2021 7 415 M 8 833 M 8 833 M
P/E ratio 2021 18,9x
Yield 2021 3,68%
Capitalization 111 B 132 B 132 B
EV / Sales 2021 3,20x
EV / Sales 2022 2,96x
Nbr of Employees 99 412
Free-Float 88,3%
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 101,51 €
Last Close Price 88,89 €
Spread / Highest target 31,6%
Spread / Average Target 14,2%
Spread / Lowest Target -15,6%
EPS Revisions
Managers and Directors
NameTitle
Paul Hudson Chief Executive Officer & Director
Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President
Serge Weinberg Chairman
John C. Reed EVP & Global Head-Research & Development
Nestle Frank Global Head-Immunology Therapeutic Research Area
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI12.95%132 466
JOHNSON & JOHNSON4.98%435 090
ROCHE HOLDING AG12.75%328 768
PFIZER, INC.7.25%220 997
NOVARTIS AG2.73%210 424
ABBVIE INC.7.23%202 939